glp 1 agonist drugs names GLP-1 I ANSE1024_0051_table_a.jpg
Description
Efficacy and safety of intranasal peptide YY3-36 for weight reduction in obese adults
Rustagi T, Jamidar PA
The fate of taspoglutide, a weekly GLP-1 receptor agonist, versus twice-daily exenatide for type 2 diabetes: the T-emerge 2 trial
Our science-backed solutions can help you restore both your health and your hope
Exenatide weekly, Liraglutide &Dulaglutide have the most reduction effect on HbA1c ( Table 3 ) Table 3: GLP-1RAs summary of head-to-head clinical trials
Always consult with a healthcare professional to determine whether any new program is appropriate for you
